These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6802545)

  • 1. The role of heparin in the changes of lipid patterns during a single hemodialysis.
    Teraoka J; Matsui N; Nakagawa S; Takeuchi J
    Clin Nephrol; 1982 Feb; 17(2):96-9. PubMed ID: 6802545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of unfavourable effects of heparin with use of gabexate mesilate in dialysis.
    Matsui N; Nakagawa S; Sasaoka T; Suenaga M; Yoshiyama N; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1979; 16():135-40. PubMed ID: 121458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of heparin-free dialysis on abnormal lipid metabolism in patients on regular dialysis treatment.
    Matsui N; Nakamura Y; Shinoda T; Iwamoto H; Yoshiyama N; Nakagawa S; Takeuchi J; Teraoka J
    Proc Eur Dial Transplant Assoc; 1980; 17():253-8. PubMed ID: 7243776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
    Wiemer J; Scherberich JE
    MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effect of heparin on lipid parameters in patients on renal replacement therapy.
    Katopodis KP; Koliousi E; Gouva C; Balafa O; Bairaktari E; Ikonomou M; Elisaf MS; Siamopoulos KC
    ASAIO J; 2007; 53(1):46-9. PubMed ID: 17237649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin does not necessarily reduce lipids and lipoproteins in hemodialysis patients.
    Kronenberg F; König P; Lhotta K; Steinmetz A; Dieplinger H
    Clin Nephrol; 1995 Jun; 43(6):399-404. PubMed ID: 7554525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of heparin-free dialysis on uremic hyperlipidemia in patients on maintenance hemodialysis. I. The change of lipids during a dialysis (author's transl)].
    Matsui N; Iwamoto H; Yoshiyama N; Nakagawa S; Takeuchi J; Teraoka J; Sasaoka T; Shoji T
    Nihon Jinzo Gakkai Shi; 1980 Nov; 22(11):1437-46. PubMed ID: 6782282
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid apheresis in an animal model causes in vivo changes in lipoprotein electrophoretic patterns.
    Cham BE; Kostner KM; Dwivedy AK; Shafey TM; Fang NX; Mahon MG; Iannuzzi CI; Colquhoun DM; Smith JL
    J Clin Apher; 1996; 11(2):61-70. PubMed ID: 8844434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
    Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
    Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
    Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum parathyroid hormone levels and lipid profile in hemodialysis patients. Evolution of lipid parameters after parathyroidectomy.
    Navarro JF; Teruel JL; Lasunción MA; Mora-Fernandez C; Ortuño J
    Clin Nephrol; 1998 May; 49(5):303-7. PubMed ID: 9617494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis.
    Kario K; Matsuo T; Yamada T; Matsuo M
    Thromb Haemost; 1994 Mar; 71(3):275-9. PubMed ID: 8029788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis: the relative pathogenetic roles of triglyceride production and triglyceride removal.
    Chan MK; Varghese Z; Persaud JW; Baillod RA; Moorhead JF
    Clin Nephrol; 1982 Apr; 17(4):183-90. PubMed ID: 7075035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid behavior during hemodialysis using heparin and prostacyclin].
    Camici M; Evangelisti L
    Minerva Med; 1992 Dec; 83(12):801-4. PubMed ID: 1491759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic heparinization of uremic patients and its effects on blood lipids and on in vitro toxicity of the plasma.
    Wessel-Aas T; Christophersen B
    Clin Nephrol; 1982 Sep; 18(3):135-40. PubMed ID: 7140025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of heparin on the lipid level during hemodialysis].
    Nikolaeva NP; Siniukhin VN; Khokhlov AP; Iarmolinskiĭ IS; Stetsiuk EA
    Urol Nefrol (Mosk); 1990; (5):31-3. PubMed ID: 2264204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of cellulose diacetate dialysis membranes on lipids and lipoproteins in uremic patients].
    Jakić M; Rupcić V; Stipanić S; Samardzija G; Bilandzija M; Zibar L; Mihaljević D; Milas J
    Lijec Vjesn; 1997 Feb; 119(2):56-9. PubMed ID: 9297037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.